Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion

AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients develop ventricular arrhythmias (VAs) responsive to anti-tachycardia pacing (ATP). However, VA episodes have not been characterized in accordance with the device therapy, and with the emergence of the subcutaneous implantable card...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarbakhsh, Shohreh, Protonotarios, Alexander, Monkhouse, Christopher, Hunter, Ross J, Elliott, Perry M, Lambiase, Pier D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202497/
https://www.ncbi.nlm.nih.gov/pubmed/37213071
http://dx.doi.org/10.1093/europace/euad073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202497/
https://www.ncbi.nlm.nih.gov/pubmed/37213071
http://dx.doi.org/10.1093/europace/euad073

Ejemplares similares